GBR-13098

Error creating thumbnail:

GBR-13098.svg

GBR-13098 is a chemical compound that has been studied for its potential effects on the central nervous system. It is classified as a dopamine reuptake inhibitor, which means it can increase the levels of dopamine in the brain by preventing its reabsorption into neurons.

Chemical Properties

GBR-13098 is a member of the piperazine class of compounds. Its chemical structure includes a piperazine ring, which is a common feature in many psychoactive drugs. The exact molecular formula and structure of GBR-13098 are essential for understanding its pharmacological properties.

Pharmacology

As a dopamine reuptake inhibitor, GBR-13098 has been shown to increase extracellular levels of dopamine. This action is similar to that of other well-known stimulants, such as cocaine and methylphenidate. By inhibiting the dopamine transporter (DAT), GBR-13098 prevents the reuptake of dopamine into presynaptic neurons, thereby increasing the concentration of dopamine in the synaptic cleft.

Potential Therapeutic Uses

Research into GBR-13098 has primarily focused on its potential use in treating disorders related to dopamine dysregulation, such as Attention Deficit Hyperactivity Disorder (ADHD) and Parkinson's disease. However, its clinical application remains largely experimental.

Side Effects and Risks

Like other dopamine reuptake inhibitors, GBR-13098 may have a range of side effects. These can include increased heart rate, elevated blood pressure, and potential for abuse and addiction. Long-term use may lead to neurotoxicity and other adverse effects on the central nervous system.

Research and Development

GBR-13098 is still under investigation, and much of the research is preclinical. Studies have been conducted to understand its pharmacokinetics, pharmacodynamics, and potential therapeutic applications. Further research is needed to fully elucidate its safety profile and efficacy in humans.

See Also

• Dopamine reuptake inhibitor
• Central nervous system
• Dopamine
• Attention Deficit Hyperactivity Disorder
• Parkinson's disease

External Links

-